BioMarin Pharmaceutical Inc
BMRN· Nasdaq
Released May 4, 2017, after the close
10-Q filed May 4, 2017, 34 days after period end · 0001564590-17-008822
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $303.75M | $236.74M | $202.92M | $151.55M |
| Net Income | -$16.29M | -$83.05M | -$67.50M | -$38.12M |
| EPS Diluted | -$0.09 |
BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR
| -$0.51 |
| -$0.43 |
| -$0.27 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.